PharmaShots | Incisive News in 3 Shots

Subscribe Now

Formosa Pharmaceuticals

Formosa Reports Top-Line Data from P-III (CPN-303) Study of APP13007 for Inflammation and Pain Post Cataract Surgery in Chinese Patients

Formosa Reports Top-Line Data from P-III (CPN-303) Study of APP13007 for Inflammation and Pain Post Cataract Surgery in Chinese Pa...

November 4, 2024

Formosa Pharmaceuticals Receives the US FDA’s Approval for Clobetasol Propionate to Treat Post-Operative Inflammation and Pain Following Ocular Surgery

Formosa Pharmaceuticals Receives the US FDA’s Approval for Clobetasol Propionate to Treat Post-Operative Inflammation and Pain Fol...

March 7, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us